Compared with normal tissues, malignant tissues had a higher PD-1 expression on T cells and PD-1+/CD8+ TILs displayed an impaired antitumor immunity that produces less IL-2 and IFN-γ and compromises the control of tumor growth [10, 11]. This evidence concerns the gene PDCD1 and neoplasm.